NuSkin Enterprises, Inc. reported Q2 2023 revenue of $320.1M, down 10% YoY, missing estimates, and delays entry into India until 2027. Adjusted EPS in line with guidance.
NuSkin Enterprises, Inc. reported Q2 2023 revenue of $320.1 million, down 10% year-over-year and missing the consensus estimate of $325 million. The decline was primarily attributed to a challenging macroeconomic environment and delays in the launch of its business in India, pushing back the anticipated market entry to 2027.
Key Takeaways
- Revenue fell to $320.1 million, down 10% YoY, primarily due to a $4 million foreign currency headwind.
- Adjusted EPS was $0.20, in line with guidance, while reported EPS was negative $5.14 due to a goodwill impairment charge of $78.9 million.
- Gross margin improved to 68.2%, despite a revenue mix shift, as core business margins rose to 77.7%.
- General and administrative expenses decreased by $15.9 million YoY, reflecting cost discipline while investing in strategic priorities.
- Guidance for Q3 anticipates revenue between $310 million and $340 million, with adjusted EPS projected at $0.10 to $0.20.
Revenue Decline Reflects Broader Challenges
NuSkin's revenue of $320.1 million represents a 10% decrease from the prior year, influenced significantly by foreign currency fluctuations. The company noted an approximate $4 million headwind due to currency issues. In addition, management has shifted their focus to recalibrating their approach to the Indian market, which has delayed entry until the first half of 2027. This setback is pivotal as India is recognized as a high-growth market for direct selling.
| Metric | Q2 2023 | YoY | QoQ |
|---|---|---|---|
| Revenue | $320.1M | -10% | N/A |
| Adjusted EPS | $0.20 | N/A | N/A |
| Gross Margin | 68.2% | -0.6% | N/A |
Strategic Shift Towards East-West Operations
Management is implementing an east-west operational model aimed at improving efficiency and aligning resources with market needs. COO Chase Clark is spearheading this transition, which is expected to generate cost savings beginning in the second half of 2023, with more substantial benefits anticipated in 2027. The shift from a seven-region structure to a more distinct east-west operation is designed to create a more agile organization, which could help NuSkin navigate challenges better and enhance profitability.
Cost Management Efforts Yield Mixed Results
NuSkin's gross margin improved to 68.2% in Q2 2023, partially driven by a better margin in the core business, which reached 77.7%. However, selling expenses as a percentage of revenue increased to 33.7%, up from 33.2% a year ago. General and administrative expenses decreased by $15.9 million, indicating a commitment to cost discipline, though this has also highlighted the challenges in managing expenses across different segments of the business.
Adjusted Guidance Reflects Continued Uncertainty
Looking forward, NuSkin has set its Q3 revenue guidance between $310 million and $340 million, factoring in a 2% to 3% foreign currency impact. The full-year revenue forecast has been adjusted to a range of $1.28 billion to $1.35 billion. Adjusted EPS for the year is expected to be in the range of $0.70 to $0.90, excluding non-cash charges and transition costs. Management's cautious outlook reflects ongoing macroeconomic pressures and the need to optimize operations before expanding into new markets.
Frequently Asked Questions
Did NuSkin Enterprises, Inc. beat earnings estimates in Q2 2023?
No, NuSkin reported adjusted EPS of $0.20, which was in line with guidance but below the consensus of $0.25.
What are the main reasons for NuSkin's revenue decline?
The revenue decline of 10% year-over-year is mainly due to foreign currency headwinds and delays in launching operations in India, a key growth market.
When is NuSkin planning to enter the Indian market?
NuSkin has postponed its market launch in India to the first half of 2027 to ensure operational readiness and proper alignment with local practices.
How are NuSkin's margins performing?
NuSkin's gross margin improved to 68.2%, with the core business achieving a margin of 77.7%, reflecting ongoing margin improvement initiatives despite overall revenue challenges.
What changes are being made to NuSkin's operational structure?
NuSkin is transitioning to an east-west operational model to better align resources and improve efficiency across its business segments, with expected cost savings starting in the second half of 2023.
The upcoming quarters will be critical for NuSkin as it seeks to stabilize operations, enhance profitability, and navigate the complexities of new market entries, particularly in India.
This analysis is based on public earnings call materials and is not investment advice.
